SentiCorn Logo
SentiCorn Logo
SentiCorn Logo
SentiCorn Logo

Catalyst Pharmaceuticals, Inc.

CPRX • US14888U1016

Health Care

20,40 €

▲ 0,00% 25.11. • 20:00

Kursentwicklung

1H 1T 1M

Medienaufmerksamkeit (30 Tage)

KI-Stimmungsanalyse

Letzte 7 Tage
4 Pos 1 Neu 0 Neg
Letzte 30 Tage
5 Pos 1 Neu 1 Neg

Neueste Nachrichten

Neutral 07.12., 13:21 • Seeking Alpha All Articles

Capricor: Maintaining 'Hold' Rating On Randomized Phase 3 HOPE-3 Trial Win With Deramiocel

Neutral 03.12., 20:47 • Investing.com News

Capricor Therapeutics stock price target raised to $51 from $29 at Jones Trading

Neutral 03.12., 18:03 • Investors Business Daily (Technology)

Capricor Skyrockets 535% After Getting Vindication In Muscular Dystrophy

Capricor stock skyrocketed to an eight-year high Wednesday on positive results for its Duchenne muscular dystrophy treatment. The post Capricor Skyrockets 535%...

Neutral 03.12., 17:07 • Seeking Alpha All Articles

Capricor Therapeutics: Shares Soaring After DMD Study Win - Ball Now In FDA's Court

Neutral 02.12., 21:43 • Seeking Alpha All Articles

Catalyst Pharmaceuticals, Inc. (CPRX) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Neutral 24.11., 18:49 • Benzinga

Martin Shkreli Takes Aim At Capricor — Stock Sinks

Capricor Therapeutics stock plummets after Martin Shkreli announces he is shorting the stock. read more

Neutral 23.11., 04:48 • Seeking Alpha All Articles

Cipher Pharmaceuticals Has Potential

Neutral 07.11., 22:35 • Seeking Alpha News

Capricor Therapeutics, Inc. Q3 2025 Earnings Preview

Neutral 07.11., 01:36 • Seeking Alpha All Articles

Catalyst Pharmaceuticals, Inc. (CPRX) Q3 2025 Earnings Call Transcript

Neutral 07.10., 14:30 • Seeking Alpha All Articles

Choice Properties: Development Pipeline Will Result In Growth

Anzeige
Werbeplatz

Marktdaten

  • Marktkapitalisierung Mid Cap
  • Branche Pharmaceuticals, Biotechnology & Life Sciences
  • Land United States
Über Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Fird...

Webseite besuchen